Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Baxter

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illnessG van den Berghe, F Weekers, R C Baxter, et al.
Biochemical and Biophysical Research Communications|October 29, 1987
Production of IGF-binding proteins by vascular endothelial cellsR S Bar, L C Harrison, R C Baxter, et al.
The Journal of Biological Chemistry|August 7, 1999
The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopyJ B Janosi, P A Ramsland, M R Mott, et al.
British Journal of Cancer|January 10, 2013
Tissue biomarkers of breast cancer and their association with conventional pathologic featuresL Chung, S Shibli, K Moore, et al.
The Biochemical Journal|January 1, 1986
Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1L C Read, F J Ballard, G L Francis, et al.
The Journal of Endocrinology|March 16, 2001
Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3M Galanis, S M Firth, J Bond, et al.
Human Reproduction (Oxford, England)|June 1, 1993
Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3)Z H Huang, R C Baxter, S M Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markersH de Boer, G J Blok, C Popp-Snijders, et al.
The Journal of Endocrinology|June 6, 1998
The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitusT D Cheetham, J M Holly, R C Baxter, et al.
Kidney International|September 18, 1997
Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic childrenD Haffner, B Tönshoff, W F Blum, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illnessG van den Berghe, F Weekers, R C Baxter, et al.
Biochemical and Biophysical Research Communications|October 29, 1987
Production of IGF-binding proteins by vascular endothelial cellsR S Bar, L C Harrison, R C Baxter, et al.
The Journal of Biological Chemistry|August 7, 1999
The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopyJ B Janosi, P A Ramsland, M R Mott, et al.
British Journal of Cancer|January 10, 2013
Tissue biomarkers of breast cancer and their association with conventional pathologic featuresL Chung, S Shibli, K Moore, et al.
The Biochemical Journal|January 1, 1986
Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1L C Read, F J Ballard, G L Francis, et al.
The Journal of Endocrinology|March 16, 2001
Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3M Galanis, S M Firth, J Bond, et al.
Human Reproduction (Oxford, England)|June 1, 1993
Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3)Z H Huang, R C Baxter, S M Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markersH de Boer, G J Blok, C Popp-Snijders, et al.
The Journal of Endocrinology|June 6, 1998
The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitusT D Cheetham, J M Holly, R C Baxter, et al.
Kidney International|September 18, 1997
Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic childrenD Haffner, B Tönshoff, W F Blum, et al.
Pageof 27